… of therapy, concomitant immunosuppressive therapy, the … infection and reduction in
immunosuppression can cause flares in … usually improve and immunosuppression is reduced [24]. …

… Tapering is influenced in most series by the ability to reduce concurrent immunosuppressive
therapy, regarded as a significant risk factor for infection-related morbidity and mortality. …

… expert recommendations for the use of extracorporeal photopheresis based on the available
… Concurrent steroid and other immunosuppressive drug doses should be recorded at each …

… immunosuppression and tolerance without the typical adverse effects normally associated
with classical immunosuppressive … connective tissue, with concomitant involvement of internal …

… In the present study, we analyze four cases of use of ECP as concomitant therapy in … burden
of immunosuppression throughout their renal diseases. Two patients had concomitant viral …

… The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma,
graft… transplant rejection: A consensus statement update from the UK Photopheresis Society. …

Extracorporeal photopheresis (ECP) is a therapy that combines the collection of mononuclear
cells by apheresis, the addition of a photosensitizer (8-methoxisoralen), the illumination of …

… strategies rely on combinations of immunosuppressants that block T cell … Extracorporeal
photopheresis (ECP) is an … In this study, concurrent or shortly after completion of investigational …

… Furthermore, concomitant immunosuppressive therapy was able to be tapered in those
patients responsive to therapy with ECP. More recently, the case of a patient with severe …

… that the combination of extracorporeal photopheresis (ECP) and … We describe here the
efficacy of the concurrent administration … Additional immunosuppressive treatments were tapered …